Careium (CARE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
11 Jun, 2026Executive summary
Achieved a positive fourth quarter with a return to growth and strong profitability, meeting the lower end of growth and upper end of profitability guidance.
Net sales grew 14.8% in Q4 2024 to SEK 228.9 million, with full-year growth of 5.6% to SEK 870.7 million, driven by both product and service sales.
Operating profit (EBIT) rose 59.3% in Q4 and 41.5% for the year, reflecting improved efficiency and higher sales.
Launched new products including the Abby mobile social alarm and i-Care Centre platform.
Renewed multi-year contract with Oslo municipality, increasing annual value from SEK 33 million to SEK 50 million.
Financial highlights
Q4 organic sales growth was 14.8% (12.5% adjusted for currency), with gross margin up to 44.4% from 40.2%.
EBITDA for Q4 rose to SEK 43.8m (19.1% margin), EBIT to SEK 26.5m (11.6% margin); full-year EBITDA was SEK 150.5m.
Free cash flow for Q4 was SEK 16.6m, with cash on hand at SEK 31.9m and net debt reduced to SEK 164.9m.
Full-year free cash flow was SEK 36.9m, down from SEK 61.9m, due to increased net working capital.
Equity ratio increased to 64.6% (from 62.4%).
Outlook and guidance
Net sales, profitability, and free cash flow before acquisitions are expected to increase in 2025.
Softer first half of 2025 anticipated due to Swedish market delays, with stronger performance expected in the second half.
Focus on launching new hardware/software innovations and expanding assisted living and direct-to-consumer offerings.
Latest events from Careium
- Sales fell 7.2% in Q3, but solid margins and innovation support 2024 growth targets.CARE
Q3 202411 Jun 2026 - Gross margin improved to 44.5% despite lower sales and profit, with growth outside Sweden.CARE
Q1 202511 Jun 2026 - Sales and profit fell, but gross margin and cash flow improved; outlook remains positive.CARE
Q2 202511 Jun 2026 - Q2 net sales rose 7.3% and EBIT increased 48.9%, led by strong growth in Germany and France.CARE
Q2 202421 May 2026 - Net sales and profit rose, but margins declined due to investments and onboarding costs.CARE
Q1 20265 May 2026 - Q4 2025 delivered modest sales growth, lower EBIT, and stronger cash flow amid margin pressure.CARE
Q4 202516 Feb 2026 - Aging demographics fuel growth in care tech, with innovation and recurring revenue driving strategy.CARE
ABGSC Investor Days12 Jan 2026 - Q3 2025 delivered 6% sales growth, higher margins, and strong product sales despite one-off costs.CARE
Q3 202524 Oct 2025